FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT

被引:0
|
作者
Yuko Suenaga
Kazuhiro Kitajima
Takeaki Ishihara
Ryohei Sasaki
Naoki Otsuki
Ken-ichi Nibu
Tsutomu Minamikawa
Naomi Kiyota
Kazuro Sugimura
机构
[1] Kobe University Graduate School of Medicine,Department of Radiology
[2] Kobe University Graduate,Department of Radiology, Division of Radiation Oncology
[3] School of Medicine,Department of Otolaryngology
[4] Kobe University Graduate,Head and Neck Surgery
[5] School of Medicine,Department of Oral and Maxillofacial Surgery
[6] Kobe University Graduate School of Medicine,Department of Medical Oncology and Hematology
[7] Kobe University Hospital,undefined
来源
European Radiology | 2016年 / 26卷
关键词
Head and neck squamous cell carcinoma (HNSCC); Recurrence; F-FDG; Positron emission tomography/computed tomography (PET/CT); Enhanced CT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1018 / 1030
页数:12
相关论文
共 50 条
  • [41] The Additional Value of FDG PET/CT in Oncology Patients Compared With Contrast-enhanced CT
    Mateva, G.
    Garcheva-Tsacheva, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S724 - S724
  • [42] FDG PET/CT Demonstration of Right Atrium Metastasis Overlooked on Contrast-Enhanced CT
    Lu, Yang
    Ulaner, Gary
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (05) : 405 - 406
  • [43] Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study
    Taghipour, Mehdi
    Mena, Esther
    Kruse, Matthew J.
    Sheikhbahaei, Sara
    Subramaniam, Rathan M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 250 - 258
  • [44] Use of FDG-PET and contrast-enhanced ultrasonography in the assessment of liver metastases
    Gonzalez Flores, Encarnacion
    Montesa, Alvaro
    Luque, Raquel
    Conde, Veronica
    Rodriguez Franco, Carlos
    Sanchez Toro, Carmen
    Medina, Antonio
    Rodriguez Fernadez, Antonio
    Llamas, J. Manuel
    Ramon Delgado, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 132 - 132
  • [45] Comparison of FDG PET/CT with contrast-enhanced CT for the detection of peritoneal carcinomatosis in patients with ovarian cancer
    Kang, Ji Yeon
    Kim, Seok-ki
    Kim, Tae Sung
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [46] Influence of contrast-enhanced FDG-PET/CT on diagnostic performance and therapy management in ENT-, lung and colorectal cancer in comparison to non-enhanced FDGPET/CT
    Strobel, K.
    Thuerl, C. M.
    Husarik, D. B.
    Hany, T. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S252 - S252
  • [47] FDG-PET/CT for staging of peritoneal carcinomatosis before peritonectomy and hyperthermic intraperitoneal chemotherapy Is there an additional benefit of contrast-enhanced CT?
    Werner, Matthias
    Aschoff, Philip
    Koenigsrainer, Ingmar
    Brendle, Cornelia
    Schwenzer, Nina
    Schraml, Christina
    Bares, Roland
    Koenigsrainer, Alfred
    Pfannenberg, Christina
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [48] FDG PET/CT compared to contrast-enhanced CT for the evaluation of T-cell Lymphoma patients
    Popescu, Cristina
    Kirienko, Margarita
    Rusconi, Chiara
    Fiorino, Stefania
    Vanzulli, Angelo
    Rossetti, Claudio
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [49] Application of Contrast-Enhanced Ultrasound (CEUS) in Lymphomatous Lymph Nodes: A Comparison between PET/CT and Contrast-Enhanced CT
    Ma, Xuelei
    Ling, Wenwu
    Xia, Fan
    Zhang, Yifan
    Zhu, Chenjing
    He, Jialing
    CONTRAST MEDIA & MOLECULAR IMAGING, 2019,
  • [50] Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test-Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
    Rockall, Andrea G.
    Avril, Norbert
    Lam, Raymond
    Iannone, Robert
    Mozley, P. David
    Parkinson, Christine
    Bergstrom, Donald
    Sala, Evis
    Sarker, Shah-Jalal
    McNeish, Iain A.
    Brenton, James D.
    CLINICAL CANCER RESEARCH, 2014, 20 (10) : 2751 - 2760